Sanofi and Har­ris Poll glob­al he­mo­phil­ia study finds ‘trou­bling dis­con­nect’ be­tween pa­tients and providers

Sanofi wants to open up con­ver­sa­tions about he­mo­phil­ia, es­pe­cial­ly be­tween peo­ple liv­ing with the con­di­tion and their doc­tors.

Dri­ving its am­bi­tion are in­sights from a new Har­ris Poll sur­vey com­mis­sioned to query pa­tients, care­givers and hema­tol­o­gists from around the world and find no­tice­able gaps be­tween pa­tients’ and providers’ per­spec­tives.

More than half (54%) of pa­tients, for ex­am­ple, re­port­ed hav­ing fair or poor health, yet 71% tell their health­care providers they are do­ing fine. On­ly 35% of pa­tients think their hema­tol­o­gist in­volves them in treat­ment dis­cus­sions. Mean­while, 84% of hema­tol­o­gists said they want pa­tients to be more in­volved in treat­ment de­ci­sions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER